Trichinella spiralis and Tumors: Cause, Coincidence or Treatment?

Chengshui Liao1,2,3, Xiangchao Cheng1, Mingyuan Liu2,3,4

  • 1The Key Lab of Animal Disease and Public Health/ College of Animal Science and Technology, Henan University of Science and Technology, Luoyang, China.

Abstract

Insights

Trichinella spiralis (T. spiralis) shows potential antitumor activities, but research is inconsistent. Further investigation is needed to clarify its role in tumor prevention and treatment.

Area of Science:

  • Oncology
  • Parasitology
  • Immunology

Background:

  • Conventional tumor treatments face limitations, necessitating novel therapeutic strategies.
  • The use of biological agents, including parasites, as cancer therapeutics is gaining interest.
  • Trichinella spiralis (T. spiralis) has been discussed in relation to human and animal tumors.

Purpose of the Study:

  • To review and analyze existing literature on the relationship between T. spiralis and tumors.
  • To explore the potential of T. spiralis as an antitumor agent.
  • To understand the dual role of T. spiralis in tumorigenesis.

Main Methods:

  • Comprehensive literature search using PubMed.
  • Review of articles published globally before 2018.
  • Synthesis of evidence regarding T. spiralis and tumor interactions.

Main Results:

  • Evidence suggests T. spiralis possesses antitumor activities, first noted in the 1970s.
  • Research on T. spiralis's antitumor effects is inconsistent, with unclear mechanisms.
  • Some studies indicate T. spiralis may contribute to tumor coinfection.

Conclusions:

  • The literature presents conflicting evidence on T. spiralis's pro- or antitumorigenic effects.
  • Further research is required to elucidate the precise relationship between T. spiralis and tumors.
  • Clinical trial data is lacking to confirm T. spiralis's role in tumor prevention or treatment.

Related Concept Videos